Is Crestchem overvalued or undervalued?

As of 19 September 2025, Crestchem's valuation grade has moved from attractive to very attractive, indicating a positive shift in its perceived value. The company is currently assessed as undervalued, especially when considering its strong performance metrics. Key ratios include a PE Ratio of 15.99, an EV to EBIT of 13.80, and a remarkable ROCE of 47.85%.
In comparison to its peers, Crestchem stands out with a significantly lower PE ratio than Solar Industries, which has a PE of 105.35, and Godrej Industries, with a PE of 39.33. Additionally, Crestchem's PEG Ratio is notably at 0.00, suggesting it is undervalued relative to its growth potential. Despite recent stock performance showing a decline year-to-date of -52.81% compared to a 5.74% gain in the Sensex, the long-term returns of 193.99% over three years and 423.37% over five years highlight its strong growth trajectory.